F3M.F Tempus AI

Healthcare Health Information Services Frankfurt Exchange
75.59 EUR
Close of Nov 12, 2026
35.79 78.23
Market cap
EUR 13.4B
P/E
-
P/B
30.49x
ROE
-36.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is F3M.F undervalued?

Graham number

The Graham number of Tempus AI cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tempus AI fundamental analysis

No fundamental analysis for Tempus AI yet.

Tempus AI stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tempus AI

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS te…

Full company profile